GLP-1 drugs , initially developed for treating type 2 diabetes , have generated significant interest due to their remarkable ability to promote a lower BMI . These new injectable approaches function by https://bookmarkleader.com/story21901193/glp-1-decoding-the-weight-loss-excitement